EGFR Gene Mutation Clinical Trials in Changsha, Hunan
2 recruitingChangsha, Hunan, China
Showing 1–2 of 2 trials
Recruiting
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Lung Cancer (Non-Small Cell)Circulating Tumor DNAEGFR-TKI Resistant Mutation+2 more
Second Xiangya Hospital of Central South University210 enrolled1 locationNCT05598528
Recruiting
Phase 2
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Non-small Cell Lung CancerALK Gene MutationEGFR Gene Mutation+2 more
Hunan Province Tumor Hospital6,000 enrolled1 locationNCT04322890